Examkin

Soru

Zorluk: ZorGynecologic Oncology

During a routine annual examination, a 63-year-old woman with a body mass index of 36 kg/m² mentions she experienced two days of mild, self-resolving vaginal spotting a month prior. She had her final menstrual period twelve years ago. Her medical history includes hypertension managed with amlodipine and type 2 diabetes mellitus managed with metformin. Vital signs are normal. A pelvic examination demonstrates atrophic external genitalia and pale vaginal walls, with no active bleeding or palpable masses. The cervix is flush with the vaginal vault. A transvaginal ultrasound is performed in the office, which shows a homogeneous endometrial stripe measuring 7 mm in thickness with no focal lesions. The adnexa are unremarkable. Based on these findings, which of the following is the most appropriate next step in the management of this patient?

  1. A
    Saline infusion sonohysterography
  2. B
    Cyclic oral medroxyprogesterone acetate therapy
  3. Office-based aspiration of the endometriumCevap
  4. D
    Reassurance and scheduling a follow-up ultrasound in 6 months
  5. E
    Initiation of topical vaginal estrogen cream

Cevap

Office-based aspiration of the endometrium
The correct answer involves obtaining tissue from the uterine cavity. This patient presents with postmenopausal bleeding and an endometrial stripe of 7 mm. In postmenopausal women, an endometrial thickness greater than 4 mm is abnormal and carries a substantial risk for endometrial hyperplasia or carcinoma. This is particularly concerning in a patient with obesity and diabetes, both of which contribute to peripheral estrogen conversion and unopposed estrogen exposure. Office-based tissue aspiration is the gold-standard initial procedure to acquire a histologic diagnosis and rule out malignancy.

Adım Adım Çözüm

1
Identify the chief complaint and patient risk factors.
The patient has postmenopausal bleeding (PMB) along with obesity and type 2 diabetes mellitus, which are significant risk factors for unopposed estrogen exposure and endometrial cancer.
Recognizing risk factors increases the clinical suspicion for malignancy in the setting of abnormal bleeding.
2
Interpret the objective ultrasound data.
The transvaginal ultrasound reveals an endometrial thickness of 7 mm.
In a postmenopausal woman, the normal threshold for endometrial thickness is 4 mm or less. A measurement of 7 mm is distinctly abnormal.
3
Determine the algorithmic next step based on findings.
Any PMB with an endometrial stripe greater than 4 mm requires direct tissue evaluation to definitively rule out endometrial hyperplasia or carcinoma.
Even though vaginal atrophy is present on the physical exam, it cannot be assumed to be the sole cause of bleeding when the ultrasound indicates a high-risk uterine pathology.
4
Select the appropriate clinical intervention.
Office-based aspiration of the endometrium is selected.
It is the safest, most cost-effective first-line method to obtain necessary tissue for histologic evaluation.

Anahtar Kavram

In postmenopausal women presenting with vaginal bleeding and an endometrial thickness greater than 4 mm on ultrasound, direct tissue evaluation is required to rule out malignancy, regardless of other concurrent benign findings like vaginal atrophy.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru